| Journal | Phytomedicine : international journal of phytotherapy and phytopharmacology |
| Study Type | Clinical Study |
| Population | Human participants |
With sarcopenia affecting up to 30% of adults over 60 and limited pharmaceutical options, identifying evidence-based natural interventions could provide clinicians additional tools for muscle preservation strategies. This review specifically examines cannabis alongside seven other medicinal plants, offering perspective on botanical approaches to age-related muscle loss.
This narrative review evaluated preclinical and clinical evidence for eight medicinal plants in managing muscle loss and sarcopenia, including Cannabis sativa among traditional Persian medicine selections. The authors conducted a comprehensive literature search across major databases without time restrictions, examining in vitro, in vivo, and clinical trial data. While the review provides broad coverage of botanical interventions for muscle health, the heterogeneous study designs and limited clinical trial data for most species, including cannabis, constrain definitive therapeutic recommendations. The inclusion of cannabis reflects growing recognition of cannabinoid system involvement in muscle metabolism and inflammation modulation.
“I see this as valuable mapping of the botanical landscape for muscle health rather than practice-changing evidence. The cannabis inclusion here reflects its anti-inflammatory properties and emerging research on cannabinoid receptors in muscle tissue, but we need dedicated sarcopenia trials with cannabis to move beyond theoretical benefit.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
- FAQ
- Can cannabis help prevent muscle loss in aging patients with sarcopenia?
- What is the mechanism by which medicinal plants like cannabis might help with muscle wasting?
- Are there clinical studies showing cannabis effectively treats muscle loss?
- How does cannabis compare to other natural therapies for muscle preservation?
- Should patients with sarcopenia consider cannabis as a treatment option?
FAQ
Can cannabis help prevent muscle loss in aging patients with sarcopenia?
This narrative review identifies Cannabis sativa as one of eight medicinal plants with potential benefits for muscle preservation, though the evidence is still emerging. The anti-inflammatory properties of cannabis compounds may theoretically support muscle health, but more clinical trials are needed to establish efficacy and safety specifically for sarcopenia management.
What is the mechanism by which medicinal plants like cannabis might help with muscle wasting?
The reviewed medicinal plants, including cannabis, appear to work through anti-inflammatory pathways and may influence muscle physiology at the cellular level. These natural compounds could potentially counteract the inflammatory processes that contribute to muscle breakdown in conditions like sarcopenia and chronic disease-related muscle loss.
Are there clinical studies showing cannabis effectively treats muscle loss?
While this review examined preclinical and clinical evidence for cannabis and seven other medicinal plants, specific clinical trial data demonstrating cannabis efficacy for muscle loss treatment remains limited. The review suggests promising potential based on traditional medicine use and early research, but robust randomized controlled trials are still needed.
How does cannabis compare to other natural therapies for muscle preservation?
Cannabis was evaluated alongside seven other medicinal plants including soy (Glycine max), olive (Olea europaea), and rosemary (Salvia rosmarinus) for muscle health benefits. All eight plants showed potential therapeutic properties, but direct comparative effectiveness data is not available, and individual responses may vary significantly.
Should patients with sarcopenia consider cannabis as a treatment option?
While cannabis shows promise as part of natural approaches to muscle health, patients should consult healthcare providers before use, especially given limited clinical evidence specific to sarcopenia. The review suggests potential benefits but emphasizes that more research is needed to establish proper dosing, safety profiles, and clinical effectiveness for muscle preservation.